Sunshine Biopharma (SBFM) Enterprise Value (2010 - 2026)
Sunshine Biopharma (SBFM) posted Enterprise Value of -$6.9 million for Q1 2026, up 24.23% on a QoQ basis from -$9.1 million in Q4 2025, and up 15.64% year-over-year from -$6.0 million in Q1 2025.
Sunshine Biopharma (SBFM) Enterprise Value (2010 - 2026) Analysis & Trends
Sunshine Biopharma's Enterprise Value history runs 16 years deep, the most recent figure standing at -$6.9 million for Q1 2026.
- Quarterly Enterprise Value rose 15.64% year-over-year to -$6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (up 15.64% YoY) and the FY2025 annual result came in at -$9.1 million, up 5.81% from the prior year.
- Enterprise Value was -$6.9 million for Q1 2026 at Sunshine Biopharma, up from -$9.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$6.9 million in Q1 2026 and bottomed at -$41.7 million in Q2 2022.
- A 5-year average of -$16.8 million and a median of -$13.2 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 2294.89% — and 2023, when it jumped 53.54%.
- Sunshine Biopharma's Enterprise Value stood at -$21.8 million in 2022, then climbed by 25.35% to -$16.3 million in 2023, then jumped by 40.55% to -$9.7 million in 2024, then increased by 5.81% to -$9.1 million in 2025, then climbed by 24.23% to -$6.9 million in 2026.
- Business Quant data shows SBFM's Enterprise Value at -$6.9 million in Q1 2026, -$9.1 million in Q4 2025, and -$9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 92.29 Bn | 90.43 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 33.09 Bn | 31.15 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.76 Bn | 23.70 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 22.94 Bn | 20.79 Bn | 648.10 Mn | -2.15 Bn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | -3.97 Mn |
| 7 | Viatris | 20.51 Bn | 18.70 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 18.16 Bn | 16.84 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.84 Bn | 12.41 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Sunshine Biopharma | 696,643.46 | -6.22 Mn | 2.18 Mn | -6.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.91 Mn |
| Dec 31, 2025 | -9.12 Mn |
| Sep 30, 2025 | -9.31 Mn |
| Jun 30, 2025 | -10.31 Mn |
| Mar 31, 2025 | -8.20 Mn |
| Dec 31, 2024 | -9.69 Mn |
| Sep 30, 2024 | -12.21 Mn |
| Jun 30, 2024 | -11.51 Mn |
| Mar 31, 2024 | -17.43 Mn |
| Dec 31, 2023 | -16.29 Mn |
| Sep 30, 2023 | -18.85 Mn |
| Jun 30, 2023 | -19.73 Mn |
| Mar 31, 2023 | -19.29 Mn |
| Dec 31, 2022 | -21.83 Mn |
| Sep 30, 2022 | -40.56 Mn |
| Jun 30, 2022 | -41.74 Mn |
| Mar 31, 2022 | -13.19 Mn |
| Dec 31, 2021 | -2.05 Mn |
| Sep 30, 2021 | -2.39 Mn |
| Jun 30, 2021 | -1.74 Mn |